Exelixis, Inc.

EXEL · Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

Exelixis, Inc. (EXEL), in the Healthcare sector, has 24 disclosed filings on Paydirt over the trailing twelve months from 13 corporate insiders: 1 purchase and 23 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 10 and filed Aug 12. The most active filer was Patrick J. Haley with 9 filings.

Add to watchlist

Filings, ttm

1 buy · 23 sells

Traders, ttm

13 insiders

Volume, ttmiDollar value disclosed in the window

$43.4M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 10

Filed Aug 12

ADViAverage daily dollar volume

$143.0M

market data

Share price · 12M

$56.35 (+42.4%)

Adjusted for splits and dividends.

Volume by month

Buys $1.2M Sells $85.2M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

PH Patrick J. Haley EVP, Commercial 9 filings DA Dana Aftab EVP, Research and Development 6 filings JH Jeffrey Hessekiel EVP & General Counsel 5 filings MB Mary C Beckerle Director 4 filings SE Sue Gail Eckhardt Director 4 filings GP George Poste Director 4 filings CS Christopher J. Senner EVP and CFO 4 filings JW Jack L Wyszomierski Director 4 filings

Recent filings

Mary C BeckerleSALE Director $527K
9,812 sh × $53.66
Exec Aug 10
Filed Aug 12 · 7:34 PM ET Sue Gail EckhardtSALE Director $492K
9,812 sh × $50.14
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Jack L WyszomierskiSALE Director $198K
3,925 sh × $50.55
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Dana AftabSALE EVP, Research and Development $2.2M
43,451 sh × $50.35
Exec May 26
Filed May 28 · 5:30 PM ET Patrick J. HaleySALE EVP, Commercial $1.6M
32,110 sh × $49.81
Exec May 20
Filed May 22 · 5:30 PM ET Brenda HeftiSALE SVP and General Counsel $333K
6,625 sh × $50.21
Exec May 18
Filed May 19 · 5:30 PM ET Christopher J. SennerSALE EVP and CFO $1.7M
34,901 sh × $50.00
Exec May 18
Filed May 19 · 5:30 PM ET George PosteSALE Director $2.7M
60,000 sh × $45.71
Exec May 7
Filed May 8 · 5:30 PM ET Maria C FreireSALE Director $949K
20,634 sh × $46.00
Exec May 7
Filed May 8 · 5:30 PM ET Mary C BeckerleSALE Director $374K
7,712 sh × $48.45
Exec May 7
Filed May 8 · 5:30 PM ET Dana AftabSALE EVP, Research and Development $2.1M
47,918 sh × $44.50
Exec Feb 24
Filed Feb 26 · 5:30 PM ET Dana AftabSALE EVP, Research and Development $1.3M
29,873 sh × $44.35
Exec Feb 19
Filed Feb 23 · 5:30 PM ET Jack L WyszomierskiSALE Director $4.4M
99,574 sh × $44.01
Exec Feb 18
Filed Feb 20 · 5:30 PM ET Julie SmithSALE Director $4.7M
106,539 sh across 3 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET Brenda HeftiSALE SVP and General Counsel $822K
18,669 sh × $44.01
Exec Feb 18
Filed Feb 18 · 5:30 PM ET Bob OliverSALE Director $1.3M
30,250 sh across 2 lots
Exec Feb 13
Filed Feb 18 · 5:30 PM ET Sue Gail EckhardtSALE Director $169K
3,856 sh × $43.79
Exec Feb 13
Filed Feb 18 · 5:30 PM ET Patrick J. HaleySALE EVP, Commercial $3.0M
67,814 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET Christopher J. SennerSALE EVP and CFO $2.8M
64,895 sh across 2 lots
Exec Feb 13
Filed Feb 18 · 5:30 PM ET David Edward JohnsonPURCHASE Director $1.2M
27,532 sh × $43.12
Exec Nov 25 2025
Filed Nov 26 2025 · 4:05 PM ET Patrick J. HaleySALE EVP, Commercial $3.0M
72,230 sh across 4 lots
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET Mary C BeckerleSALE Director $1.0M
24,622 sh across 2 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET Dana AftabSALE EVP, Research and Development $2.1M
48,383 sh × $42.50
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET Stelios PapadopoulosSALE Director $4.4M
100,000 sh × $43.55
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET Jack L WyszomierskiSALE Director $325K
7,535 sh × $43.09
Exec Jun 3 2025
Filed Jun 4 2025 · 5:30 PM ET